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ABSTRACT
Mammalian DNA ligase III (LigIII) functions in both
nuclear and mitochondrial DNA metabolism. In the
nucleus, LigIII has functional redundancy with DNA
ligase I whereas LigIII is the only mitochondrial DNA
ligase and is essential for the survival of cells de-
pendent upon oxidative respiration. The unique LigIII
zinc finger (ZnF) domain is not required for catalytic
activity but senses DNA strand breaks and stimulates
intermolecular ligation of two DNAs by an unknown
mechanism. Consistent with this activity, LigIII acts
in an alternative pathway of DNA double strand break
repair that buttresses canonical non-homologous
end joining (NHEJ) and is manifest in NHEJ-defective
cancer cells, but how LigIII acts in joining inter-
molecular DNA ends versus nick ligation is unclear.
To investigate how LigIII efficiently joins two DNAs,
we developed a real-time, fluorescence-based as-
say of DNA bridging suitable for high-throughput
screening. On a nicked duplex DNA substrate, the
results reveal binding competition between the ZnF
and the oligonucleotide/oligosaccharide-binding do-
main, one of three domains constituting the LigIII cat-
alytic core. In contrast, these domains collaborate
and are essential for formation of a DNA-bridging in-
termediate by adenylated LigIII that positions a pair
of blunt-ended duplex DNAs for efficient and specific
intermolecular ligation.
INTRODUCTION
DNA end joining by DNA ligase enzymes is essential for
the replication, rearrangement and repair of DNA (1).
Mammalian DNA ligases I, III and IV share a conserved,
three-domain catalytic core that consists of the DNA bind-
ing domain (DBD), nucleotidyltransferase (NTase) do-
main and oligonucleotide/oligosaccharide binding domain
(OBD) (2). Unique regions flanking the conserved core of
each enzyme interact with proteins orDNA to support their
specialized functions in DNAmetabolism (2).While almost
all eukaryotes have homologs of LigI and LigIV, LigIII is
present in vertebrates but absent from ∼70% of eukary-
otes, including Saccharomyces cerevisiae and Schizosaccha-
romyces pombe. Mammalian LigIII functions in both nu-
clear and mitochondrial DNA metabolism (3). Expression
of the mitochondrial isoform of LigIII is essential for mam-
malian development and for cell growth under conditions
requiring mitochondrial respiration (4–6). Mitochondrial
DNA repair appears to be limited to a subset of the repair
activities found in the nucleus (7). Mitochondrial LigIII is
most strongly implicated in base excision repair (BER) and
replication of mtDNA (8), but is not essential for cell vi-
ability in appropriate media (6). Nuclear LigIII forms a
constitutive heterodimer with the repair scaffolding pro-
tein XRCC1, whereas mitochondrial LigIII functions inde-
pendently of XRCC1 (9). A knockdown of LigIII expres-
sion sensitizes cells to oxidative damage and slows recovery
from mtDNA depletion following DNA damage (10). Un-
der normal growth conditions, knockdowns of LigIII have
variable effects on steady-state levels of mtDNA that may
depend on the extent of the knockdown (3,6). However, se-
lective depletion of the mitochondrial isoform of LigIII al-
ters the character of mtDNA replication intermediates, pro-
viding compelling evidence for the participation of LigIII
in mtDNA replication (10). Finally, overexpression of mi-
tochondrial LigIII protects cells against oxidative stress by
increasing BER of damaged mtDNA, suggesting that liga-
tion is the rate limiting step in mitochondrial BER (11).
In the nucleus, the LigIII/XRCC1 complex is recruited to
damaged chromatin by the enzymatic activity of poly(ADP-
ribose) polymerase 1 (PARP-1) (12). XRCC1 accelerates the
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repair ofDNAsingle-stranded breaks in concert withLigIII
(13) or DNA ligase I (14). However, LigIII can also func-
tion as a sensor of DNA strand breaks independently of
PARP-1, serving to recruit other DNA repair proteins to
sites of damage (15). LigIII has been implicated in the repair
of DNA double strand breaks (DSBs) by microhomology-
mediated end joining (16) or by a noncanonical pathway
of DSB repair termed the alternative non-homologous end
joining (A-NHEJ) pathway (17–19) when the classical Ku-
dependent pathway (C-NHEJ) is inactivated by mutation.
Cancerous cells overexpressing LigIII appear to be hyper-
reliant on A-NHEJ for DSB repair (20–22), a phenotype
that could be exploited for cancer therapy.
The unique N-terminal zinc finger (ZnF) domain of
LigIII binds to DNA nicks or structural irregularities in
duplex DNA (15,23–25). The ZnF also binds to PARP-
1 (26) and this protein–protein interaction may facilitate
DSB repair by the A-NHEJ pathway (27). The LigIII ZnF
is homologous to the PARP-1 domains ZnF1 and ZnF2,
which bind to DNA breaks and activate PARP-1 enzymatic
activity (28). The isolated ZnF of LigIII binds weakly to
nicked DNA and cooperates with the adjacent DBD to
form a functional DNA binding module, the ZnF–DBD,
with higher affinity than either the ZnF or DBD alone (29).
In the context of the LigIII protein, the ZnF domain does
not pack against the core catalytic domains (DBD–NTase–
OBD) when the enzyme is bound to a nicked DNA (30).
This was evident from the large radius of gyration (Rg)
for LigIII constructs containing the ZnF, on or off DNA.
The ZnF imbues the protein with characteristics of flexible
or unfolded residues that are consistent with a highly ex-
tended or fluctuating conformation of the ZnF, disengaged
from the DNA while the core of the enzyme encircles the
nicked DNA (30). These findings have suggested that the
ZnF binds only transiently to DNA single strand breaks,
prior to end joining by the enzyme’s catalytic core.
The ZnF–DBD is adjacent to another independent DNA
binding module in LigIII consisting of the NTase and
OBDdomains. TheNTase–OBDbinds to duplexDNAand
maintains a weak DNA nick joining activity in the absence
of the Znf–DBD (29). Tryptophan quenching studies have
revealed twoDNAbinding activities for LigIII with low and
high affinity for duplex DNA (31) that may reflect the bind-
ing activities of the ZnF–DBD and NTase–OBD regions,
respectively. Two adjacent DNA binding modules in LigIII
could serve to align two DNA molecules for intermolecu-
lar ligation. Yet, a crystal structure of LigIII lacking the
ZnF revealed a compact arrangement of the DBD–Ntase–
OBD domains encircling a nicked DNA that excludes the
ZnF from accessing the DNA nick, which is buried by the
NTase andOBDdomains (30). These results raise questions
of when and how the ZnF engages DNA during LigIII-
dependent repair of DNA strand breaks (see Figure 1A).
The ZnF has a modest effect on the DNA nick-joining
activity of LigIII when assayed at high salt concentrations
(32), but it is essential for efficient intermolecular ligation
of two DNAs (30). To investigate the physical organiza-
tion of two DNAs in complex with LigIII and the role
of its ZnF, we developed a series of assays that reveal the
presence of a stable and specific DNA bridging complex in
which one molecule of LigIII closely apposes the ends of
two DNAs prior to ligation. With this assay, we character-
ized a sustained binding activity of the ZnF, which assem-
bles the enzyme–substrate complex for the intermolecular
joining of twoDNAs.We refer to this ligation reaction inter-
mediate as the LigIII DNA bridging complex. This bridg-
ing complex requires LigIII adenylation, Mg2+ ions and
matched DNA ends with no mismatches: consistent with
the relevance of bridging to the DNA end joining reaction.
Whereas the ZnF and OBD domains collaborate to bind
two molecules of DNA in this bridging complex, there is
a binding competition between these domains on a nicked
DNA duplex. Taken together these results inform the dis-




Oligonucleotides were synthesized on a 1 mol scale using
an Applied Biosystem 394 DNA-RNA synthesizer, HPLC
purified and desalted using SepPak C18 cartridge (Waters).
The 5′-modified oligonucleotides were prepared by incor-
poration of biotin, fluorescein isothiocyanate (FITC) and
PO4 phosphoramidite monomers (Glen Research). To gen-
erate dsDNA substrates, equal amounts of complementary
oligonucleotides were mixed in 25 mM MES (pH6.5) and
50 mM of NaCl. The oligonucleotide mixture was heated
to 95◦C and then allowed to anneal by slowly cooling
to room temperature in a water bath. A 5′-biotinylated
oligonucleotide (biotin-5′-AGTGAATTCGAGCTCG-3′)
was annealed with a complementary oligonucleotide
(5′-AATCGAGCTCGCAATTCACT-3′) to create a biotin
labeled duplex with a 3-nt, 5′ overhang (underlined). The
double-stranded DNA was labeled with the FRET donor
terbium (Tb3+) by incubating the DNA with 10 nM Tb3+-
streptavidin (Life Technologies; Figure 1) in the reaction
mixture incubated at room temperature. A 5′ FITC labeled
oligo (FITC-5′-CATGATTACGG-3′) was annealed with
a complementary oligo (5′-ATTCCGTAATCATG-3′) to
create a duplex with a 5′ overhang (underlined) that is
complementary to the Tb3+ labeled DNA above. The blunt
ended DNAs for time-resolved fluorescence resonance
energy transfer (TR-FRET) and ligation assays were
prepared with the same sequences listed above, but without
the 3-nt overhanging ends. DNA substrates for enzymatic
ligation were prepared by synthetic incorporation of a
5′-PO4 group in the unlabeled DNA strand of each duplex.
Full length DNA LigIII (residues 1–862), which we re-
fer to as LigIII throughout this manuscript, was cloned
with an N-terminal His-tag in the pQE32 expression vec-
tor (Qiagen) and purified by a previously reported proto-
col (29). The ZnF deleted construct (ZnF LigIII; residues
170–749) was cloned with anN-terminal His-tag in pET28a
(Novagen) and the construct deleted for the OBD domain
(OBDLigIII; residues 1–595) was clonedwithC terminal-
his tag in the pET28a vector (Novagen). ZnF LigIII
was purified using a published protocol for the slightly
largerZnFLigIII spanning residues 170–862 (23).OBD
LigIII was expressed in Escherichia coli Rosetta 2 (DE3)
cells at 16◦C temperature. Cells were lysed by sonication
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Figure 1. Tandem DNA binding surfaces of LigIII support DNA bridging. (A) The LigIII protein (LigIII, 862 residues) spans four structural domains,
an N-terminal zinc finger (ZnF; residues 1–100), a DNA binding domain (DBD; residues 170–390), a nucleotidyl transferase domain (NTase; residues
391–595) and the OB-fold domain (OBD; residues 596–749) that are required for efficient DNA end joining activity. Two pairs of domains, the ZnF–DBD
and the NTase–OBD, comprise independent DNA binding modules (29) that are required in DNA bridging activity (cf. Figure 4B). The crystal structure
of ZnF LigIII bound to a nicked DNA reveals a compact structure that would preclude the ZnF domain from binding to the nick (PDB 3L2P) (30). (B)
We developed a time resolved FRET (TR-FRET) assay to measure intermolecular ligation of two DNAs by LigIII. In this assay, LigIII brings together
DNAs labeled with Tb3+ (donor) and FITC (acceptor) to produce a FRET signal. DNA bridging activity and efficient intermolecular ligation of DNAs
depend on the presence of the ZnF domain. We present evidence that this DNA bridging complex is a reaction intermediate of the intermolecular ligation
pathway.
chromatography. After washing the column with buffer A
(50 mM Tris–HCl 7.5, 200 mM NaCl, 0.5 mM TCEP, 10%
Glycerol and protease inhibitors (PMSF, benzamidine, le-
upeptin and aprotinin) containing 50 mM imidazole, the
protein was eluted with buffer A containing 300 mM imi-
dazole. The eluted protein was loaded on a heparin affinity
column (GE Health care) in buffer A containing 100 mM
NaCl then eluted with a gradient of 0.1 M to 1 M NaCl.
Fractions containing a single band corresponding to the pu-
rified OBD LigIII were pooled and loaded on Superdex
200 column (10/300 GL; GE Health Care) then eluted in
buffer containing 50mMTris–HCl 7.5, 200mMNaCl, 10%
glycerol, 0.1 mM ethylenediaminetetraacetic acid (EDTA),
1 mM dithiothreitol (DTT). Purified proteins were concen-
trated to 30–40 mg/ml concentration and stored at −80◦C.
TR-FRET assay
The time resolved FRET (TR-FRET) assay described by
Chen et al. (33) was adapted to examine the DNA binding
and bridging activity of LigIII. The TR-FRET assay was
carried out in solid black 384-well flat bottom plates (Corn-
ing) and binding activity was monitored using a Synergy2
multi-plate reader (Bio-Tek). The binding reaction was ini-
tiated bymixing LigIII (100 nM) with a mixture of the Tb3+
and FITC labeled DNA duplexes (500 nM each) in a 20-
l reaction volume of TR-FRET buffer (50 mM HEPES-
NaOH 7.5, 80 mM NaCl, 5 mM MgCl2, 1 mM DTT, 1
mM adenosine triphosphate (ATP) and 50 g/ml bovine
serum albumin; BSA) at room temperature. We confirmed
that the order of component addition was inconsequential
for the resulting TR-FRET signal. LigIII and the DNAs
were stable in the assay conditions and could be preincu-
bated separately for more than 1 h before mixing to initi-
ate the binding reaction. For TR-FRET measurements, the
Tb3+ donor was excited at 340 nm and, after a delay of 100
s, the emission intensities of the Tb3+ donor (495 nm) and
the FITC acceptor (520 nm) were recorded. The TR-FRET
signal is expressed as an intensity ratio (520/495 nm). The
time courses shown in Figures 2–5 are the average of three
replicate binding reactions. A time delay between initiating
the binding reaction and recording the TR-FRET data was
accounted for in the data analysis. The amplitude of the TR-
FRET signal is highly reproducible for replicate samples
within an experiment, but varies (range of 1.5–2.5) accord-
ing to the DNA labeling efficiency and the age of labeled
DNAs. A limiting concentration of LigIII (100 nM) is used
in our standard assay conditions in order to promote the
formation of a 1:2 complex with one LigIII bound to two
DNAs (cf. Figure 7B).
DNA end joining activity
Intermolecular DNA end joining activity catalyzed by
LigIII was measured with DNA substrates containing com-
plementary, 3-nt overhanging ends under multiple turnover
conditions at 25◦C.The reaction buffer andDNAsequences
are the same as used in the TR-FRET assay, but the ligat-
able DNAs contain a 5′-PO4 on the unlabeled DNA strand,
whereas the 5′ end of the other strand is blocked with FITC
or biotin. The ligation reaction was initiated by mixing the
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Figure 2. DNA bridging precedes intermolecular DNA ligation. (A) The real time measurement of TR-FRET (520/495 nm) signals the assembly of a
DNA bridging complex, in which LigIII juxtaposes two DNAs labeled with donor and acceptor labels. Ligation reactions containing a pair of DNAs with
complementary 3-nt overhangs were assembled in the absence (red) or presence (blue) of LigIII and the TR-FRET signal was monitored. The TR-FRET
traces shown in Figures 2–5 are the average values of assays performed in triplicate. DNA ligation activity measured under the same reaction conditions
(B) is plotted as the percentage of total DNA in the ligation product (green). (B) The time course of DNA ligation under the same reaction conditions as
in (A) was monitored by running timed reaction aliquots on a 18% denaturing urea Polyacrylamide gelelectrophoresis (PAGE). DNA ligation activity is
significantly slower than the TR-FRET signal, which results from the LigIII dependent juxtaposition of the labeled DNAs. The intermolecular ligation of
a blunt-end DNA (Supplementary Figure S5) is markedly slower than ligation of overhanging DNA ends, suggesting that the end structure of the DNAs
influences the rate-limiting step of ligation. (C) The same rapid onset of the TR-FRET signal is observed upon addition of LigIII (blue) to a pair of DNAs
with 5′-OH groups that cannot be ligated, whereas the TR-FRET value remains at baseline in the absence of LigIII (red). Thus, DNA bridging complex
formation is rapid and precedes DNA ligation (A). (D) PAGE analysis of the reaction with non-ligatable DNAs used in (C) shows that no ligated product
is formed under conditions that produce the TR-FRET signal corresponding to DNA bridging activity.
l reaction volume. The time course of the ligation reaction
was monitored by removing 10 l aliquots and quenching
activity with EDTA-formamide at 95◦C for 5–10 min. The
FITC labeled 11-mer substrate was separated from 30-mer
ligation product by urea acrylamide gel electrophoresis un-
der denaturing conditions. The substrate and product bands
were visualized by fluorescence scanning with a Typhoon
FLA 7000 image analyzer (GEHealthcare) using excitation
at 495 nm and emission at 520 nm. The progress of the liga-
tion reaction was measured from the fluorescence intensity
of the product band and expressed as a percentage of the to-
tal fluorescence of the substrate and product bands in each
sample.
Pull-down of LigIII–DNA complexes
The DNA bridging complex was pulled down with a
biotinylated DNA immobilized on streptavidin magnetic
beads (Spherotech). Streptavidin magnetic beads (30 l)
were washed three times with 0.5 ml of wash buffer (10
mM HEPES-NaOH (7.0), 1 M NaCl, 5 mM DTT) then
incubated with a nonligatable, 5′-biotinylated DNA duplex
(500 nM) in a 100 l reaction volume for 2 h at 4◦C. Beads
were then washed three more times with wash buffer by
vortexing the beads, magnetic trapping of the beads and
removal of the supernatant. The beads were subsequently
blocked with wash buffer containing 50 g/ml BSA for 30
min at 4◦C then washed extensively with TR-FRET buffer
prior to use. To form the DNA bridging complex, LigIII or
Znf LigIII (200 nM final concentration) was added to the
washed beads in a 100 l reaction volume and incubated
for 30 min at 4◦C. Beads were washed 4–5× with 0.5 ml
TR-FRET buffer and a 5′-FITC labeled DNA duplex with
non-ligatable ends (500 nM) was added in a 100 l reac-
tion volume and incubated for 30 min at 4◦C. Beads were
subsequently washed 3–4× with TR-FRET buffer and the
5′-FITCDNAwas eluted from the beads by addition of 1%
sodium dodecyl sulphate solution (40 l). The amount of
FITC-labeled DNA recovered from the beads was quanti-
fied by fluorescence intensity measured at 520 nm in solu-
tion or by running samples on 18% Urea polyacrylamide
gelelectrophoresis and imaging the 5′-FITC oligos with the
Typhoon imager, as described above for the DNA ligation
assay. The specificity of binding was tested in control reac-
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DNA binding affinity and stoichiometry determinations
The DNA binding affinities of different LigIII constructs
were determined using non-ligatable, FITC labeled DNAs
containing either a 3-nt overhang or a blunt end. TheDNAs
(25 nM) were titrated with LigIII proteins (0–1000 nM)
in a 200 l reaction volume of TR-FRET buffer. The de-
crease in DNA concentration caused by addition of differ-
ent volumes of LigIII was taken into account in the analy-
sis of the data. Samples were incubated in a 3 mm cuvette
incubated at 25◦C and fluorescence anisotropy was mea-
sured with a QuantaMaster C-60 spectrofluorimeter (Pho-
ton Technology International) using excitation and emis-
sion wavelengths of 495 and 520 nm, respectively. The ap-
parent equilibriumdissociation constants (Kapp) were calcu-
lated by fitting the data to Equation (1) shown below (34):
r = r 0 + (rmax − r 0) ∗ f (1)
where r is the fluorescence anisotropy determined experi-
mentally and
f = p ∗ d




















To determine the stoichiometry of DNA binding by
LigIII, the florescence anisotropy experiment was repeated
at DNA concentrations more than four-fold above the ex-
perimentally determined Kapp values (Supplementary Table
S1). The DNAs (800 or 1600 nM) were titrated with LigIII
(0–3 M) in 200 l of TR-FRET buffer and the change in
fluorescence anisotropy was measured in three independent
experiments for each titration. The mean values are shown
in Figure 7, and in all cases, the standard deviations were
<5% of the mean values.
Small angle X-ray scattering
LigIII and ZnF LigIII were adenylated with 5 mM of
MgCl2 and 1 mM of ATP for 2 h at 4◦C then the reaction
was stopped by adding 10mMof EDTA. Proteins were dia-
lyzed with a buffer containing 50 mMHEPES-NaOH (7.5),
80 mMNaCl, 1 mM EDTA, 5 mMDTT and 10% glycerol.
For protein–DNA complexes different versions of LigIII
were incubated with non-ligatable (5′-OH) nicked and 3 nt
overhang at a 1:3 ratio of protein toDNA.LigIII was bound
to a DNA with a non-self complementary overhang in the
buffer described above. The protein–DNA complex was pu-
rified on a Superdex 200 10/300GL (GE healthcare) size ex-
clusion column and the presence of DNA in the complex
was confirmed by the absorbance ratio of A260: A280. At-
tempts to examine the DNA bridging complex using SAXS
were unsuccessful because of sample aggregation at the mi-
cromolar concentrations of protein and DNA required for
SAXS.
SAXS data for LigIII in complex with a non-bridging
DNA were collected at beamline 12.3.1 of the Advanced
Light Source, Lawrence Berkeley National Lab (Berkeley,
CA, USA) (35,36). Incident X-rays were tuned to a wave-
length () of 1.03 A˚ at a sample-to-detector distance of 1.5
m resulting in scattering vectors (q) ranging from 0.007 to
0.31 A˚−1. The scattering vector is defined as q= 4 sin(/),
where 2 is the scattering angle. All experiments were per-
formed at 20◦C and data were processed as described pre-
viously (35). The SAXS data for different protein concen-
trations were examined for aggregation using Guinier plots
(37), in order to choose suitable samples for further analysis.
The radius of gyration RG was derived by the Guinier ap-
proximation I(q) = I(0) exp (−q2 Rg2/3) with the limits q·Rg
< 1.3. The program GNOM (38) was used to compute the
pair-distance distribution functions, P(r) and Dmax. Kratky
plots (q2 x I(q) versus q) of each dataset were prepared to as-
sess the globular or Gaussian chain-like nature of the pro-
tein in solution.
RESULTS
Formation of a DNA bridging complex
In contrast to mammalian DNA ligases I and IV, LigIII can
efficiently join twoDNAs with cohesive or blunt ends, with-
out the use of molecular crowding agents like PEG (39,40).
The unique N-terminal ZnF domain of LigIII contributes
strongly to blunt end DNA ligation activity (23,29) by an
unknown mechanism. LigIII contains four domains that
can open or close around dsDNA (Figure 1A). Here, we
characterized the assembly of the corresponding enzyme–
substrate complex, using a TR-FRET assay (33). Our as-
say incorporates two double-stranded DNAs with cohesive
or blunt ends (see ‘Materials and Methods’ section). One
strand of each DNA duplex in the reaction is labeled on
a 5′ end either with a biotin that is conjugated with Tb3+-
labeled streptavidin (the FRET donor) or with the FRET
acceptor FITC (Figure 1B). Upon addition of LigIII to
a pair of DNAs with ligatable ends, the TR-FRET signal
increases rapidly and reaches a maximum within minutes
(Figure 2A). The increase in TR-FRET occurs faster than
the rate of DNA ligation measured under the same condi-
tions with the labeled DNAs (Figure 2A and B). This obser-
vation suggested that the TR-FRET signal is reporting on
a LigIII dependent activity in which two DNA molecules
are brought into apposition before intermolecular ligation.
In fact, substituting a pair of non-ligatable DNAmolecules
with 5′-OH and 3′-OH ends produced the same rapid in-
crease in FRET upon addition of LigIII (Figure 2 C) with-
out formation of ligation product (Figure 2D). We there-
fore refer to this early step of the reaction, prior to covalent
ligation of DNAs, as a DNA bridging complex. A limiting
concentration of LigIII is used in the bridging assay to pro-
mote the formation of a 1:2 complex of one LigIII molecule
bound to two DNAs (see below). The TR-FRET signal ob-
tained in the bridging assay (TR-FRET = 1.5–2.0) is corre-
spondingly less than the maximum value (TR-FRET= 3.0)
measured for a control DNA that incorporates the FRET
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Figure 3. Bridging requires compatible pairs of DNA ends. Pairs of non-
ligatable DNAs with either complementary three nucleotide overhangs
(blue) or with blunt ends (green) generated a FRET signal in the presence
of LigIII, indicative of DNA bridging activity. In contrast, two mispaired
combinations consisting of two DNAs with blunt and overhanging ends
(orange, magenta) did not support TR-FRET and resulted in a baseline
level of fluorescence.
The DNA binding specificity of LigIII in the bridging
complex was investigated using DNAs that lack a 5′-PO4
and cannot be ligated together. DNA ligase I and LigIII
both discriminate strongly against ligation substrates with
mispaired bases located near the 5′-PO4 and 3′-OH ends
of a DNA strand break at physiological salt concentra-
tions (32,41). This substrate selectivity for correctly paired
bases at the ends enhances the fidelity of DNA ligation by
preventing the aberrant joining of DNA breaks with un-
matched overhangs (29,41). Here we found that the forma-
tion of the DNA bridging complex also requires matched
DNA ends. Addition of LigIII to a pair of labeled DNAs
with blunt ends or complementary 3 nt overhangs gener-
ates the FRET signal, whereas a mixture of DNAs with un-
matched ends does not support the DNA bridging interac-
tion (Figure 3). This finding suggests that the ends of the
DNAs are in close contact with one another in the bridg-
ing complex, as expected for a productive enzyme–substrate
complex. The specificity of the DNA bridging complex was
further tested by a competitive binding reaction with un-
labeled DNA. The TR-FRET signal is completely blocked
by addition of an eight-fold excess of unlabeled DNA (4
M) to a reaction containing 0.5 Mof each labeled DNA
(Figure 4A). The observed binding competition is consis-
tent with a discrete and saturable DNA binding surface of
LigIII that maintains the bound configuration of DNAs in
the bridging complex. The rate of dissociation of the labeled
DNA from the bridging complex (0.1 min−1; Supplemen-
tary Figure S2 and Methods) was estimated in the presence
of a saturating concentration of an unlabeled competitor.
Adenylation of LigIII is essential for bridging complex for-
mation
During the first chemical step of DNA ligation, LigIII is
adenylated on an active site lysine (Lys 421 in humanLigIII)
using ATP as the substrate. Recombinant LigIII protein pu-
rified from E. coli consists of an approximately equal mix-
ture of adenylated and unmodified protein molecules (30).
Correspondingly, the TR-FRET signal amplitude gener-
Figure 4. Specificity of DNA bridging by LigIII. (A) The DNA binding
activity of LigIII in the DNA bridging assay is effectively competed by an
unlabeled DNA, saturable manner, as expected for the formation of a dis-
crete protein–DNA complex. A pair of labeled, non-ligatable DNAs (500
nM of each) was incubated with LigIII (100 nM) in the presence of in-
creasing concentrations of an unlabeled DNA duplex (0–8 M). See also
Supplementary Figure S2. (B) In the absence of added ATP (light blue) the
TR-FRET signal amplitude is about 50% of the signal for a reaction con-
tainingATP (100M; dark blue). LigIII that was completely deadenylated
(orange) did not support DNA bridging and TR-FRET. (C) Addition of
ATP to the deadenylated LigIII (shown in B) restored the TR-FRET sig-
nal and DNA bridging activity in a concentration-dependent manner. The
TR-FRET values 30 min after addition of ATP are shown.
ated in the absence of added ATP is about 50% of the signal
amplitude in the presence of a saturating amount of ATP
(Figure 4B), implying that unmodified LigIII does not sup-
port DNA bridging activity. We confirmed this conclusion
using unmodified LigIII, which was prepared by incubation
with inorganic pyrophosphate to reverse the adenylation
chemistry then exchanged into our standard assay buffer
by gel filtration chromatography. Deadenylated LigIII does
not support TR-FRET activity (Figure 4B), but addition
of ATP to the deadenylated enzyme fully restores bridging
activity (Figure 4C). The adenylation status of LigIII does
not affect DNA binding activity towards a single DNA du-
plex (Supplementary Figure S4), consistent with the inde-
pendent DNA binding activity of the ZnF–DBD that is un-
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Figure 5. DNA bridging requires two independent DNA binding surfaces
of LigIII. (A) Addition of EDTA (5 mM) abolishes the DNA bridging ac-
tivity of LigIII in reaction buffer containing 5 mMMgCl2, indicating that
divalent metal(s) are required for DNA binding activity. (B) Deletion mu-
tants of LigIII lacking the ZnF (ZnFLigIII) or OBD (OBDLigIII) do-
mains do not form the DNA bridging complex although both mutants can
bind to double-strandedDNA (Supplementary Table S1). Amixture of the
ZnF and OBD LigIII proteins also fails to bridge the labeled DNAs,
consistent with a single molecule of LigIII mediating the DNA bridging
activity (cf. Figure 7).
used in this reaction contain a 5′-OH end instead of a 5′-
PO4, which prevents transfer of the adenylate group from
LigIII to the 5′-PO4 of the DNA (step 2) and subsequent
ligation of the bound DNAs (step 3). We conclude that
adenylation of LigIII, and not the subsequent transfer of
the adenylate to DNA, is required for DNA bridging activ-
ity. The prerequisite for adenylation of LigIII supports the
relevance of bridging to the DNA end joining reaction. It is
reminiscent of the loss of DNA binding activity caused by
mutation of lysine-adenylate acceptor residue in viral DNA
ligases (42,43).
Magnesium ions are essential for three chemical steps of
the ligation reaction (1). At saturating concentrations of
Mg2+, the efficiency of ligation is high and all three steps
of the reaction occur at similar rates. However, under con-
ditions of limiting Mg2+ the final step of DNA phospho-
diester bond formation becomes rate-limiting and the 5′-
adenylated DNA intermediate accumulates (44). The addi-
tion of 5 mM EDTA completely abolishes DNA bridging
complex formation by LigIII (Figure 5A), showing the im-
portance of Mg2+ ions for the stable interaction of adeny-
lated LigIII with two complementary DNAs.
The ZnF and OBD domains of LigIII are both required for
DNA bridging
We next examined the roles of LigIII domains other than
the adenylation domain in DNA bridging activity. The ZnF
domain of LigIII is described as a DNA nick-sensor (23,32)
that contributes onlymodestly to the ligation ofDNAsingle
strand breaks in vitro (29) The ZnF is not required to com-
plement LigA-deficient E. coli (32) or to rescue the lethal-
ity of knocking out the mitochondrial isoform of LigIII in
mammalian cells (4). However, the ZnF domain is required
for the highly efficient, intermolecular DNA ligation activ-
ity that is a hallmark of LigIII (23,29). Accordingly, a dele-
tion of the ZnF domain completely abolishes the formation
of the bridging complex (Figure 5B), implicating the ZnF–
DBD as one of the key DNA interaction surfaces in the
complex.
The OBD is a conserved domain of mammalian DNA
ligases with dual roles in promoting the step 1 adenylation
reaction (17) and for DNA binding activity in cooperation
with the adjacent NTase domain (30). Deletion of the OBD
eliminates the DNA bridging activity of LigIII (Figure 5B),
which implicates theNTase–OBDas the secondDNAbind-
ing module in the bridging complex. The ZnF-LigIII and
OBD-LigIII retain DNA binding activity (Supplemen-
tary Table S1) but fail to support DNA bridging individu-
ally or in a 50:50mixture of themutant proteins (Figure 5B).
The requirement for the ZnF and OBD domains in cis sug-
gests that LigIII uses both of these DBDs in the bridging
complex. Correspondingly, human DNA ligase I, which is
homologous to LigIII but lacks a ZnF domain, does not ex-
hibit DNA bridging activity (Supplementary Figure S1B).
Structural dynamics of LigIII DNA binding modules
Mammalian DNA ligases are flexible, multidomain pro-
teins that adopt an elongated shape in the absence of DNA
(45,46) and a compact, ring-shaped structure in complex
with a nicked DNA (30,34). However, small angle x-ray
scattering (SAXS) data for LigIII are consistent with a
highly elongated shape even when bound to DNA (Fig-
ures 1A and 6A) (30). Kratky plots of the x-ray scatter-
ing data highlight the flexibility of LigIII on and off of
DNA, exhibiting non parabolic behavior with longer de-
cays at high q-values (Figure 6B). Deletion of the ZnF do-
main sharpens the pair distribution function p(r) of the mu-
tant LigIII in complex with DNA (Figure 6D) (30), and
the Kratky plot for this complex exhibits a near parabolic
shape indicative of a compact or globular protein (Figure
6E). These results suggest that the ZnF domain is flexible
and not stably bound to a nicked DNA, whereas the DBD,
NTase and OBD domains bind in a compact arrangement
consistent with the crystal structure of this complex (30).
In the crystal structure of ZnF LigIII, the DNA nick is
buried by the NTase and OBD domains and this would ap-
pear to prevent the ZnF domain from binding to the DNA
nick (30).
We reasoned that the ZnF andOBDdomainsmight com-
pete for binding to DNA ends, and perhaps bind sequen-
tially to DNA during a ligation reaction. To examine pos-
sible alternative binding modes of the ZnF and OBD do-
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Figure 6. The ZnF and OBD domains bind to overlapping sites on DNA. Small angle X-ray scattering reveals the dynamic interactions of LigIII and
deletionmutants in the 1:1 complex described in Figure 7A. (A) The normalized pair distribution function p(r) is consistent with an elongated conformation
of LigIII in the presence or absence of a DNA duplex containing a three nucleotide overhang. (B) A normalized Kratky plot of the scattering data shows
evidence of flexible residues in the presence or absence of DNA, which is modeled as a flexible ZnF domain in panel (C). (D) Deletion of the ZnF (ZnF
LigIII) significantly narrows the p(r) distribution and reveals a large conformational transition upon binding to DNA. (E) The normalized Kratky plot
of ZnF LigIII in complex with DNA shows a bell shaped Gaussian curve, indicative of a compact structure when bound to DNA. (F) The SAXS data
are consistent with a model of ZnF LigIII encircling the DNA end as for the crystal structure of ZnF LigIII bound to nicked DNA (30). (G) Deletion
of the C-terminal OBD domain (OBD LigIII) narrows the pair distribution function p(r) of LigIII in a manner similar to deletion of the ZnF domain.
This result suggests that the ZnF can engage DNA when the OBD is deleted, resulting in a compact conformation of OBD LigIII bound to DNA. (H) A
normalized Kratky plot of OBD LigIII bound to DNA reveals a Gaussian curve consistent with a compact structure with the ZnF engaging the bound
DNA as modeled in panel (I).
OBDLigIII in the absence and presence of DNA contain-
ing a 3 nt, non-self complementary overhang (Figure 6) or a
nicked DNA duplex (Supplementary Table S2). The ZnF
and OBD LigIII proteins show a comparable sharpening
of their p(r) distributions in comparison to intact LigIII,
when bound to DNA. Kratky plots confirm that the ZnF
and OBD LigIII mutants exhibit less residual flexibility
than intact LigIII when bound to DNA (Figure 6). These
results show that the DNA binding activity of the ZnF do-
main is modulated by the OBD, with overlapping binding
sites on a nicked DNA or an unpaired DNA with a non-
self-complementary overhang. This binding competition is
eliminated by deletion of the ZnF or the OBD, and both of
these deletion mutants assemble into a compact structure
when bound to DNA (Figure 6D-I). However, the ZnF and
OBD cooperate rather than compete when twoDNAs inter-
act with LigIII in a bridging configuration, requiring both
of these domains as well as the DBD and NTase domain
(Figure 5B).
One molecule of LigIII bridges two DNA molecules
The DNA binding stoichiometry of LigIII was measured
for a blunt-ended, nonligatable DNA under conditions that
support bridging complex formation and for a DNA with
an overhanging end that cannot self-pair and does not sup-
port DNA bridging activity. DNA binding activity was
monitored by fluorescence anisotropy using high concen-
trations of the FITC-labeled DNAs (800 or 1600 nM) in or-
der to promote stoichiometric binding by LigIII (KDNA of
∼150 nM; Supplementary Table S1) (29). For the unpaired
DNAwith an overhang, theDNAbinding activity of LigIII
saturates at a 1 : 1 molar ratio of protein:DNA (Figure 7A).
For the blunt-ended DNA that forms a bridging complex
(Figure 7B), the binding activity of LigIII saturates at a
0.5:1 ratio corresponding to one molecule of LigIII bound
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Figure 7. Onemolecule of LigIII binds twomolecules ofDNA in the bridg-
ing complex. (A) The DNA binding activity of LigIII was monitored by
fluorescence anisotropy of a labeled DNA under conditions of stoichio-
metric binding. A 5′ FITC labeled duplex (800 nM) containing a three nu-
cleotide overhang that cannot pair with itself was titrated with increasing
concentrations of LigIII and the change in fluorescence anisotropy was
measured. The DNA concentration in this assay is ∼5-fold higher than
the apparent equilibrium binding constant (Kapp ∼ 154 nM) determined
with limiting concentrations of DNA and LigIII in excess. The measured
binding stoichiometry of 1:1 for the LigIII:DNA complex was additionally
confirmed by repeating the titration experiment at a higher concentration
of DNA (1600 nM; not shown). (B) A binding stoichiometry of 1:2 (ratio
= 0.5) was measured for LigIII in complex with a 5′ FITC labeled, blunt-
ended DNA duplex (800 nM) that can form the DNA bridging complex.
The same binding stoichiometry was determined in a binding reaction con-
taining a higher concentration of the DNA (1600 nM; not shown).
The DNA bridging complex is stable
The physical stability of the DNA bridging complex with
LigIII was assessed by a pull-down assay. A 5′-biotinylated
dsDNA was immobilized on streptavidin-coated magnetic
beads and the beads were incubated with LigIII and subse-
quently with a FITC-labeled DNA (Figure 8A). The DNAs
in this assay have compatible overhangs but lack a 5′-PO4
and cannot be ligated together. DNA bridging activity was
measured by eluting the FITC-labeledDNA from the beads
after extensivewashing to remove unboundDNA.LigIII ef-
ficiently captured the FITC-labeled DNA on beads with an
immobilized, complementary DNA, but not on beads lack-
ing the immobilized DNA (Figure 8A). The ZnF LigIII
did not support DNA bridging activity in this assay (Fig-
ure 8B) in agreement with the TR-FRET assay results (Fig-
ure 5B). This experiment was repeated with blunt-ended
DNAs, which are also efficiently pulled down in the DNA
bridging complex (Supplementary Figure S3). However, a
pair of mismatched DNAs consisting of a FITC-labeled,
blunt-ended DNA and an immobilized DNA with an over-
hanging end did not show bridging activity in this assay
(data not shown). These pull-down experiments reveal a sta-
ble complex between LigIII and two DNAs with blunt ends
or matching overhangs, as for an intramolecular ligation re-
action.
DISCUSSION
The existence of multiple mammalian DNA ligases makes
it important to understand their distinct features that allow
them to function in different replication and repair path-
ways (1). LigIII is therefore of special interest for its func-
tions in multiple pathways and for its ZnF domain that
flanks the conserved, three-domain ligase core (2). In par-
ticular, the efficient joining of duplex DNAs by LigIII por-
tends a mechanism for aligning two DNA substrates in the
enzyme active site. We previously showed that LigIII con-
tains two independent DNA binding modules correspond-
ing to the ZnF–DBD and the NTase–OBD (29). Here we
show these dual DNA binding modules contribute to the
assembly of a stable complex with one molecule of LigIII
bound to twomolecules ofDNA.The resultingDNAbridg-
ing complex closely apposes two compatible DNA ends for
ligation, either blunt ends or short overhangs that can base
pair. The DNA bridging complex with LigIII is remark-
ably long-lived for an enzyme–substrate complex and can
be pulled down with an immobilized DNA. Modification
of the LigIII active site with an adenylate group, catalyzed
during the first step of the three-step ligation reaction, is
required for bridging in the equilibrium binding condition
for TR-FRET and in the pull-down experiment. This again
places the bridging complex in the reaction pathway for in-
termolecular ligation, as a precursor to DNA end joining.
The unique ZnF domain of LigIII is required for bridging
between two DNA molecules in addition to its previously
characterized DNA nick-sensing function (15,32,47). This
finding underscores the importance of the ZnF for inter-
molecular DNA joining activity (29,47). The DNA binding
specificity for assembly of the bridging complex assembly is
suggestive of a function for the ZnF in holding two DNA
substrates in close apposition prior to intermolecular lig-
ation, raising the possibility that the ZnF-dependent DNA
bridging activity of LigIII contributes to the repair of DSBs
inmammalian cells byA-NHEJ in the nucleus (48) and pos-
sibly during the replication or repair of mtDNA (11,18). It
is notable that the rate of intermolecular DNA ligation lags
only slightly behind the rate of bridging complex assembly
for DNAs with overhanging ends (Figure 2A). The rate of
blunt endDNA ligation ismuch slower than assembly of the
bridging complex (Supplementary Figure S5), which sug-
gests that correct alignment of the DNA ends within the
bridging complex may be rate-limiting for ligation activity.
We have developed a fluorescence-based assay monitor-
ing the juxtaposition of two DNAs by LigIII in a manner
consistent with an intermolecular DNA ligation reaction.
This real-time assay performed in a multi-well format is
suitable for high-throughput screening for inhibitors, which
may be useful tools to understand the biological functions
of the unique ZnF domain of LigIII and other aspects of
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Figure 8. LigIII is stably bound to two DNAs in the bridging complex. (A) Streptavidin magnetic beads coated with a 5′ biotinylated DNA duplex were
used to capture LigIII together with a 5′ FITC labeled DNA in a pull-down assay. The FITC labeled DNA on the beads was analyzed by urea PAGE and
quantification of fluorescence emission intensity in the gel (see ‘Materials and Methods’ section). (B) Upper panel, denaturing urea PAGE analysis of the
FITC labeled DNA recovered from the beads. Lower panel, quantitation of fluorescence intensity in the gel. Samples 4 and 5 are replicates containing
LigIII in a bridging complex. Samples 9 and 10 are replicates containing the ZnF LigIII mutant protein, which does not form the bridging complex.
Figure 8 shows the pull-down of DNAs with complementary 3 nt overhangs in complex with LigIII. Additional controls are shown in the legend above
the gel. Supplementary Figure S3 shows the pull-down of a LigIII DNA bridging complex incorporating two blunt-ended DNAs.
assay identifies the formation of a DNA bridging complex
that aligns two DNAs for covalent ligation. Assembly of
the bridging complex requires blunt-ended duplexDNAs or
complementary overhangs that can base pair, plus adenyla-
tion of the active site Lys 421. It may therefore prove useful
scientifically or medically to employ this or other assays to
develop small molecules that target the bridging complex by
blocking the ZnF conformation or other aspects of the com-
plex assembly as well as the LigIII active site chemistry. Fur-
thermore, the role of the ZnF in forming stable and specific
DNA bridging complex in which one molecule of LigIII
closely apposes the ends of two DNAs prior to ligation sug-
gests that the ZnF and the bridging complex identified here
provides a specificity step prior to the ligation chemistry.
The ZnF thus likely contributes to both specificity and effi-
ciency of DNA LigIII in joining separate DNAs with com-
patible ends.
ACKNOWLEDGEMENT
We thank members of the Ellenberger research group and
members of the National Cancer Institute program Struc-
tural Cell Biology of DNA Repair for helpful discussions.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
FUNDING
National Institutes of Health [GM052504 to T.E., P01
CA92584 to J.A.T., A.T., T.E., ES0112512 to A.T.]. Fund-
ing for the open access charge: Institutional startup funds.
Conflict of interest statement.None declared.
REFERENCES
1. Tomkinson,A.E., Vijayakumar,S., Pascal,J.M. and Ellenberger,T.
(2006) DNA ligases: structure, reaction mechanism, and function.
Chem. Rev., 106, 687–699.
2. Ellenberger,T. and Tomkinson,A.E. (2008) Eukaryotic DNA ligases:
structural and functional insights. Annu. Rev. Biochem., 77, 313–338.
3. Lakshmipathy,U. and Campbell,C. (2001) Antisense-mediated
decrease in DNA ligase III expression results in reduced
mitochondrial DNA integrity. Nucleic Acids Res., 29, 668–676.
4. Simsek,D., Furda,A., Gao,Y., Artus,J., Brunet,E.,
Hadjantonakis,A.-K., Van Houten,B., Shuman,S., McKinnon,P.J.
and Jasin,M. (2011) Crucial role for DNA ligase III in mitochondria
but not in Xrcc1-dependent repair. Nature, 471, 245–248.
5. Gao,Y., Katyal,S., Lee,Y., Zhao,J., Rehg,J.E., Russell,H.R. and
McKinnon,P.J. (2011) DNA ligase III is critical for mtDNA integrity
but not Xrcc1-mediated nuclear DNA repair. Nature, 471, 240–244.
6. Shokolenko,I.N., Fayzulin,R.Z., Katyal,S., McKinnon,P.J.,
Wilson,G.L. and Alexeyev,M.F. (2013) Mitochondrial DNA ligase is
dispensable for the viability of cultured cells, but essential for mtDNA
maintenance. J. Biol. Chem., 288, 26594–26605.
7. Liu,P. and Demple,B. (2010) DNA repair in mammalian
mitochondria: Much more than we thought? Environ. Mol. Mutagen.,
51, 417–426.
8. Alexeyev,M., Shokolenko,I., Wilson,G. and LeDoux,S. (2013) The
maintenance of mitochondrial DNA integrity–critical analysis and
update. Cold Spring Harb. Perspect. Biol., 5, a012641.
9. Lakshmipathy,U. and Campbell,C. (2000) Mitochondrial DNA
ligase III function is independent of Xrcc1. Nucleic Acids Res., 28,
3880–3886.
10. Ruhanen,H., Ushakov,K. and Yasukawa,T. (2011) Involvement of
DNA ligase III and ribonuclease H1 in mitochondrial DNA
replication in cultured human cells. Biochim. Biophys. Acta, 1813,
2000–2007.
11. Akbari,M., Keijzers,G., Maynard,S., Scheibye-Knudsen,M.,
Desler,C., Hickson,I.D. and Bohr,V.A. (2014) Overexpression of










Nucleic Acids Research, 2015 11
and improves mitochondrial DNA base excision repair. DNA Repair
(Amst), 16, 44–53.
12. El-Khamisy,S.F., Masutani,M., Suzuki,H. and Caldecott,K.W.
(2003) A requirement for PARP-1 for the assembly or stability of
XRCC1 nuclear foci at sites of oxidative DNA damage. Nucleic Acids
Res., 31, 5526–5533.
13. Caldecott,K.W., McKeown,C.K., Tucker,J.D., Ljungquist,S. and
Thompson,L.H. (1994) An interaction between the mammalian
DNA repair protein XRCC1 and DNA ligase III.Mol. Cell. Biol., 14,
68–76.
14. Katyal,S. and McKinnon,P.J. (2011) Disconnecting XRCC1 and
DNA ligase III. Cell Cycle, 10, 2269–2275.
15. Abdou,I., Poirier,G.G., Hendzel,M.J. and Weinfeld,M. (2014) DNA
ligase III acts as a DNA strand break sensor in the cellular
orchestration of DNA strand break repair. Nucleic Acids Res., 43,
875–892.
16. Liang,L., Deng,L., Nguyen,S.C., Zhao,X., Maulion,C.D., Shao,C.
and Tischfield,J.A. (2008) Human DNA ligases I and III, but not
ligase IV, are required for microhomology-mediated end joining of
DNA double-strand breaks. Nucleic Acids Res., 36, 3297–3310.
17. Wang,H., Rosidi,B., Perrault,R., Wang,M., Zhang,L., Windhofer,F.
and Iliakis,G. (2005) DNA ligase III as a candidate component of
backup pathways of nonhomologous end joining. Cancer Res., 65,
4020–4030.
18. Oh,S., Harvey,A., Zimbric,J., Wang,Y., Nguyen,T., Jackson,P.J. and
Hendrickson,E.A. (2014) DNA ligase III and DNA ligase IV carry
out genetically distinct forms of end joining in human somatic cells.
DNA Repair (Amst), 21, 97–110.
19. Soni,A., Siemann,M., Grabos,M., Murmann,T., Pantelias,G.E. and
Iliakis,G. (2014) Requirement for Parp-1 and DNA ligases 1 or 3 but
not of Xrcc1 in chromosomal translocation formation by backup end
joining. Nucleic Acids Res., 42, 6380–6392.
20. Tomkinson,A.E. and Sallmyr,A. (2013) Structure and function of the
DNA ligases encoded by the mammalian LIG3 gene. Gene, 531,
150–157.
21. Tobin,L.A., Robert,C., Rapoport,A.P., Gojo,I., Baer,M.R.,
Tomkinson,A.E. and Rassool,F.V. (2013) Targeting abnormal DNA
double-strand break repair in tyrosine kinase inhibitor-resistant
chronic myeloid leukemias. 32, 1784–1793.
22. Tobin,L.A., Robert,C., Nagaria,P., Chumsri,S., Twaddell,W.,
Ioffe,O.B., Greco,G.E., Brodie,A.H., Tomkinson,A.E. and
Rassool,F.V. (2012) Targeting abnormal DNA repair in
therapy-resistant breast cancers.Mol. Cancer Res., 10, 96–107.
23. Taylor,R.M., Whitehouse,C.J. and Caldecott,K.W. (2000) The DNA
ligase III zinc finger stimulates binding to DNA secondary structure
and promotes end joining. 28, 3558–3563.
24. Kulczyk,A.W., Yang,J.-C. and Neuhaus,D. (2004) Solution structure
and DNA binding of the zinc-finger domain from DNA ligase
IIIalpha. J. Mol. Biol., 341, 723–738.
25. Caldecott,K.W., Aoufouchi,S., Johnson,P. and Shall,S. (1996)
XRCC1 polypeptide interacts with DNA polymerase beta and
possibly poly (ADP-ribose) polymerase, and DNA ligase III is a novel
molecular ‘nick-sensor’ in vitro. 24, 4387–4394.
26. Leppard,J.B., Dong,Z., Mackey,Z.B. and Tomkinson,A.E. (2003)
Physical and functional interaction between DNA ligase IIIalpha and
poly(ADP-Ribose) polymerase 1 in DNA single-strand break repair.
Mol. Cell. Biol., 23, 5919–5927.
27. Simsek,D., Brunet,E., Wong,S.Y.-W., Katyal,S., Gao,Y.,
McKinnon,P.J., Lou,J., Zhang,L., Li,J., Rebar,E.J. et al. (2011) DNA
ligase III promotes alternative nonhomologous end-joining during
chromosomal translocation formation. PLoS Genet., 7, e1002080.
28. Langelier,M.-F., Planck,J.L., Roy,S. and Pascal,J.M. (2011) Crystal
structures of poly(ADP-ribose) polymerase-1 (PARP-1) zinc fingers
bound to DNA: structural and functional insights into
DNA-dependent PARP-1 activity. J. Biol. Chem., 286, 10690–10701.
29. Cotner-Gohara,E., Kim,I.-K., Tomkinson,A.E. and Ellenberger,T.
(2008) Two DNA-binding and nick recognition modules in human
DNA ligase III. J. Biol. Chem., 283, 10764–10772.
30. Cotner-Gohara,E., Kim,I.-K., Hammel,M., Tainer,J.A.,
Tomkinson,A.E. and Ellenberger,T. (2010) Human DNA ligase III
recognizes DNA ends by dynamic switching between two
DNA-bound states. Biochemistry, 49, 6165–6176.
31. Stankova,K., Ivanova,K., Mladenov,E., Rosidi,B., Sharma,A.,
Boteva,R. and Iliakis,G. (2012) Conformational transitions of
proteins engaged in DNA double-strand break repair, analysed by
tryptophan fluorescence emission and FRET. Biochem. J., 443,
701–709.
32. Mackey,Z.B., Niedergang,C., Murcia,J.M., Leppard,J., Au,K.,
Chen,J., de Murcia,G. and Tomkinson,A.E. (1999) DNA ligase III is
recruited to DNA strand breaks by a zinc finger motif homologous to
that of poly(ADP-ribose) polymerase. Identification of two
functionally distinct DNA binding regions within DNA ligase III. J.
Biol. Chem., 274, 21679–21687.
33. Chen,X.C., Hentz,N.G., Hubbard,F., Meier,T.I., Sittampalam,S. and
Zhao,G. (2002) Development of a fluorescence resonance energy
transfer assay for measuring the activity of Streptococcus
pneumoniae DNA ligase, an enzyme essential for DNA replication,
repair, and recombination. Anal. Biochem., 309, 232–240.
34. Pascal,J.M., O’Brien,P.J., Tomkinson,A.E. and Ellenberger,T. (2004)
Human DNA ligase I completely encircles and partially unwinds
nicked DNA. Nature, 432, 473–478.
35. Hura,G.L., Menon,A.L., Hammel,M., Rambo,R.P., Poole,F.L.,
Tsutakawa,S.E., Jenney,F.E., Classen,S., Frankel,K.A., Hopkins,R.C.
et al. (2009) Robust, high-throughput solution structural analyses by
small angle X-ray scattering (SAXS). Nat. Methods, 6, 606–612.
36. Classen,S., Hura,G.L., Holton,J.M., Rambo,R.P., Rodic,I.,
McGuire,P.J., Dyer,K., Hammel,M., Meigs,G., Frankel,K.A. et al.
(2013) Implementation and performance of SIBYLS: a dual
endstation small-angle X-ray scattering and macromolecular
crystallography beamline at the Advanced Light Source. J. Appl.
Crystallogr., 46, 1–13.
37. Guinier,A. and Fournet,G. (1947) Correction of measurements of
low-angle X-ray scattering. Nature, 160, 501.
38. Konig,S., Svergun,D.I., Koch,M.H., Hubner,G. and Schellenberer,A.
(1992) Synchrotron radiation solution X-ray scattering study of the
pH dependence of the quaternary structure of yeast pyruvate
decarboxylase. Biochemistry, 31, 8726–8731.
39. Chen,L., Trujillo,K., Sung,P. and Tomkinson,A.E. (2000)
Interactions of the DNA ligase IV-XRCC4 complex with DNA ends
and the DNA-dependent protein kinase. J. Biol. Chem., 275,
26196–26205.
40. Hayashi,K., Nakazawa,M., Ishizaki,Y. and Obayashi,A. (1985)
Influence of monovalent cations on the activity of T4 DNA ligase in
the presence of polyethylene glycol.Nucleic Acids Res., 13, 3261–3271.
41. Bhagwat,A.S., Sanderson,R.J. and Lindahl,T. (1999) Delayed DNA
joining at 3′ mismatches by human DNA ligases. Nucleic Acids Res.,
27, 4028–4033.
42. Sriskanda,V. and Shuman,S. (1998) Chlorella virus DNA ligase: nick
recognition and mutational analysis. Nucleic Acids Res., 26, 525–531.
43. Sekiguchi,J. and Shuman,S. (1997) Nick sensing by vaccinia virus
DNA ligase requires a 5′ phosphate at the nick and occupancy of the
adenylate binding site on the enzyme. J. Virol., 71, 9679–9684.
44. Taylor,M.R., Conrad,J.A., Wahl,D. and O’Brien,P.J. (2011) Kinetic
mechanism of human DNA ligase I reveals magnesium-dependent
changes in the rate-limiting step that compromise ligation efficiency.
J. Biol. Chem., 286, 23054–23062.
45. Pascal,J.M., Tsodikov,O.V., Hura,G.L., Song,W., Cotner,E.A.,
Classen,S., Tomkinson,A.E., Tainer,J.A. and Ellenberger,T. (2006) A
flexible interface between DNA ligase and PCNA supports
conformational switching and efficient ligation of DNA.Mol. Cell,
24, 279–291.
46. Ochi,T., Gu,X. and Blundell,T.L. (2013) Structure of the catalytic
region of DNA ligase IV in complex with an Artemis fragment sheds
light on double-strand break repair. Structure, 21, 672–679.
47. Taylor,R.M., Whitehouse,J., Cappelli,E., Frosina,G. and
Caldecott,K.W. (1998) Role of the DNA ligase III zinc finger in
polynucleotide binding and ligation. 26, 4804–4810.
48. Rassool,F.V. and Tomkinson,A.E. (2010) Targeting abnormal DNA





 School Library on July 6, 2015
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
